ATP-binding cassette transporter ABCB5 gene is expressed with variability in malignant melanoma

Actas Dermo-Sifiliograficas

Volumn 101, Issue 4, 2010, Pages 341-348

  Vsquez Moctezuma, I ^a   Meraz Ros, M A ^b   Villanueva Lpez, C G ^a   Magaa, M ^c   Martnez Macias, R ^c   Snchez Gonzlez, D J ^d   Garca Sierra, F ^e   Herrera Gonzlez, N E ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b Instituto Politcnico Nacional (CINVESTAV IPN)   (Mexico)

^c HOSPITAL GENERAL DE MÉXICO   (Mexico)

^d Escuela Mdico Militar   (Mexico)

^e DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Expresi n diferencial de genes; Expresi n g nica; Gen ABCB5; Melanoma

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER B5; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RESISTANCE; CELL FUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; DNA SEQUENCE; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MELANOMA; MEXICO; MOLECULAR CLONING; PATHOGENESIS; PRIMARY TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; STEM CELL;

ADULT; AGED; AGED, 80 AND OVER; ATP-BINDING CASSETTE TRANSPORTERS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOMA; MIDDLE AGED; SKIN NEOPLASMS; YOUNG ADULT;

EID: 77952182852     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.ad.2009.12.006     Document Type: Article

References (36)

1. M. Lens, and M. Dawes Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma Br J Dermatol 150 2004 179 185
2. M. Magaa, J. Cazarn, and L. Magaa Caractersticas del melanoma en la poblacin mexicana Actas Dermatol Dermatopathol (Mx) 1 2001 59 62
3. F. Meier, K. Satyamoorthy, M. Nesbit, M.Y. Hsu, B. Schittek, and C. Garbe Molecular events in melanoma development and progression Front Biosci 3 1998 1005 1010
4. B. Bastian, A. Olshen, P. LeBoit, and D. Pinkel Classifying melanocytic tumors based on DNA copy number changes Am J Pathol 3 2003 1765 1770
5. W. Berger, L. Elbling, M. Minai-Pour, M. Vetterlein, R. Pirker, and E.M. Kokoschka Intrinsic MDR-1 gene and P-glycoprotein expression in human melanoma cell lines Int J Cancer 59 1994 717 723
6. S. Ambudkar, S. Dey, C. Hrycyna, M. Ramachandra, I. Pastan, and M.M. Gottesman Biochemical, cellular, and pharmacological aspects of the multidrug transporter Annu Rev Pharmacol Toxicol 39 1999 361 398
7. R. Juliano, and V. Ling A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants Biochemical Biophysical Acta 455 1976 152 162
8. A. Fojo, K. Ueda, D. Slamon, D.G. Poplack, M.M. Gottesman, and I. Pastan Expression of a multidrug-resistance gene in human tumors and tissues Proc Natl Acad Sci USA 84 1978 265 269
9. M. Dean, A. Rzhetsky, and R. Allikmets The human ATP-binding cassette (ABC) transporter superfamily Genome Res 11 2001 1156 1166 (Pubitemid 32677289)
10. D. Shen, A. Fojo, I. Roninson, J.E. Chin, R. Soffir, and I. Pastan Multidrug resistance of DNA mediated transformants is linked to transfer of the human mdr1 gene Mol Cell Biol 6 1986 4039 4045
11. T. Schatton, G. Murphy, N. Frank, K. Yamaura, A.M. Waaga-Gasser, and M. Gasser Identification of cells initiating human melanomas Nature 451 2008 345 349
12. S. Hoffmeyer, O. Burk, O. Von Ritcher, H.P. Arnold, J. Brockmller, and A. Johne Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of the one allele with P-glycoprotein expression and activity in vivo Proc Natl Acad Sci USA 97 2000 3473 3478
13. M. Soengas, and S. Lowe Apoptosis and melanoma chemoresistance Oncogene 23 2003 3138 3151
14. P. Liang, and A. Pardee Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction Science 257 1992 967 971
15. J. Lohmann, H. Schickle, and T. Bosch REN display, a rapid and efficient method for nonradioactive differential display and mRNA isolation Biotechniques 18 1995 200 202
16. N. Frank, S. Pendse, P. Lapchak, A. Margaryan, D. Shlain, and C. Doeing Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter J Biol Chem 278 2003 47156 47165
17. Y. Huang, P. Anderle, K. Bussey, C. Barbacioru, U. Shankavaram, and Z. Dai Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance Cancer Res 64 2004 4294 4301
18. J. Kurebayashi, T. Otsuki, H. Kunisue, K. Tanaka, S. Yamamoto, and H. Sonoo Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer Clin Cancer Res 6 2000 512 518
19. M. Maia, C. Russo, N. Ferrari, and M.C.S.A. Ribeiro Acral lentiginous melanoma: a challenge for early diagnosis An Bras Dermatol 78 2003 553 560
20. B.E. Gonzalez, E. Ziv, N. Coyle, S.L. Gomez, H. Tang, and A.J. Karter The importance of race and ethnic background in biomedical research and clinical practice N Engl J Med 348 2003 1170 1175
21. R. Cooper, J. Kaufman, and R. Ward Race and genomics N Engl J Med 248 2003 1166 1170
22. B. Bastian, P. LeBoit, H. Hamm, E.B. Brocker, and D. Pinkel Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization Cancer Res 58 1998 2170 2175
23. B. Bastian, P. LeBoit, and D. Pinkel Genomic approaches to skin cancer diagnosis Arch Dermatol 137 2001 1507 1511
24. H. Davies, G.R. Bignell, C. Cox, P. Stephens, S. Edkins, and S. Clegg Mutation of the B-RAF gene in human cancer Nature 417 2002 949 954
25. J. Maldonado, J. Fridlyand, H. Patel, A.N. Jain, K. Busam, and T. Kageshita Determinants of B-RAF mutations in primary melanomas J Natl Cancer Inst 95 2003 1878 1890
26. M. Liscovitch, and Y. Lavie Cancer multidrug resistance: a reviewof recent drug discovery research Drugs 5 2002 349 355
27. K. Chen, G. Szakcs, J. Annereau, F. Rouzaud, X.J. Liang, and J.C. Valencia Principal expression of two mRNA isoforms, (ABCB 5alpha and ABCB 5beta) of the ATP-binding cassette transporter gene ABCB5 in melanoma cells and melanocytes Pigment Cell Res 18 2005 102 112
28. N. Frank, A. Margaryan, Y. Huang, T. Schatton, A.M. Waaga-Gasser, and M. Gasser ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma Cancer Res 65 2005 4320 4333
29. G. Giaccone, and H. Pinedo Drug resistance Oncologist 1 1996 82 87
30. R. Weinstein, S. Jakate, J. Domnguez, M. Lebovitz, G. Koukoulis, and J. Kuszak Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis Cancer Res 51 1991 2720 2726
31. K. Chen, J. Valencia, B. Lai, G. Zhang, J.K. Paterson, and F. Rouzaud Melanosomal sequestration of cytotoxic drugs contributes to the intractability of malignant melanomas Proc Natl Acad Sci USA 103 2006 9903 9907
32. C. Perniciaro Dermatopathologic variants of malignant melanoma Mayo Clin Proc 3 1997 273 279
33. M. Poetsch, C. Woenckhaus, T. Dittberner, M. Pambor, G. Lorenz, and F.H. Herrmann Significance of the small subtelomeric area of chromosome 1, (1p36.3) in the progression of malignant melanoma: FISH deletion screening with YAC DNA probes Virchows Arch 435 1999 105 111
34. J. Sohn, S. Lee, S. Lee, E.J. Kim, S.I. Cha, and Ch.H. Kim MDR1 polymorphisms predict the response to etoposidecisplatin combination chemotherapy in small cell lung cancer Jpn J Clin Oncol 36 2006 137 141
35. L. Duncan, J. Deeds, J. Hunter, J. Shao, L.M. Holmgren, and E.A. Woolf Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis Cancer Res 58 1998 1515 1520
36. M. Rodolfo, M. Daniotti, and V. Vallacchi Genetic progression of metastatic melanoma Cancer Lett 214 2004 133 147